1. Home
  2. TSHA vs BWB Comparison

TSHA vs BWB Comparison

Compare TSHA & BWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • BWB
  • Stock Information
  • Founded
  • TSHA 2019
  • BWB 2005
  • Country
  • TSHA United States
  • BWB United States
  • Employees
  • TSHA N/A
  • BWB N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • BWB Major Banks
  • Sector
  • TSHA Health Care
  • BWB Finance
  • Exchange
  • TSHA Nasdaq
  • BWB Nasdaq
  • Market Cap
  • TSHA 334.1M
  • BWB 365.0M
  • IPO Year
  • TSHA 2020
  • BWB 2018
  • Fundamental
  • Price
  • TSHA $1.61
  • BWB $14.08
  • Analyst Decision
  • TSHA Strong Buy
  • BWB Strong Buy
  • Analyst Count
  • TSHA 8
  • BWB 2
  • Target Price
  • TSHA $6.63
  • BWB $17.50
  • AVG Volume (30 Days)
  • TSHA 2.1M
  • BWB 64.4K
  • Earning Date
  • TSHA 02-26-2025
  • BWB 01-29-2025
  • Dividend Yield
  • TSHA N/A
  • BWB N/A
  • EPS Growth
  • TSHA N/A
  • BWB N/A
  • EPS
  • TSHA N/A
  • BWB 1.03
  • Revenue
  • TSHA $9,915,000.00
  • BWB $106,036,000.00
  • Revenue This Year
  • TSHA N/A
  • BWB N/A
  • Revenue Next Year
  • TSHA N/A
  • BWB $12.13
  • P/E Ratio
  • TSHA N/A
  • BWB $13.67
  • Revenue Growth
  • TSHA N/A
  • BWB N/A
  • 52 Week Low
  • TSHA $1.19
  • BWB $10.52
  • 52 Week High
  • TSHA $4.32
  • BWB $16.00
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 46.14
  • BWB 46.10
  • Support Level
  • TSHA $1.46
  • BWB $13.70
  • Resistance Level
  • TSHA $1.76
  • BWB $15.11
  • Average True Range (ATR)
  • TSHA 0.15
  • BWB 0.36
  • MACD
  • TSHA 0.01
  • BWB -0.06
  • Stochastic Oscillator
  • TSHA 39.33
  • BWB 23.87

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About BWB Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc offers retail and commercial loan and deposit services to customers within the Minneapolis-St. Paul-Bloomington, MN-WI Metropolitan Statistical Area. The company engages in providing a wide range of deposit and lending products. Its products and services include commercial deposits, loans, online business services, credit card, mobile banking, and remote deposit services.

Share on Social Networks: